@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . ou:urlScopus ; dcterms:contributor "Almoguera B. et al."; ou:bibtex "@article{Dorado2013,title = {CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment},journal = {Pharmacogenetics and Genomics},year = {2013},volume = {23},number = {11},pages = {627-630},author = {Almoguera, B. and Riveiro-Alvarez, R. and Lopez-Castroman, J. and Dorado, P. and Vaquero-Lorenzo, C. and Fernandez-Piqueras, J. and Llerena, A. and Abad-Santos, F. and Baca-Garc{\\'i}a, E. and Dal-R{\\'e}, R. and Ayuso, C.}}"; ou:urlOrcid ; bibo:doi "10.1097/fpc.0b013e3283659a94"; vivo:identifier "2013-683"; dcterms:creator "Almoguera B."; dcterms:publisher "Pharmacogenetics and Genomics"; ou:eid "2-s2.0-84886597555"; bibo:eissn "1744-6880"; fabio:hasPublicationYear "2013"; bibo:issn "1744-6872"; ou:tipoPublicacion "Article"; a ou:Publicacion; dcterms:title "CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment"; bibo:page_range "627-630"; vcard:url ; ou:vecesCitado "31"^^xsd:integer; bibo:volume "23"; ou:publicadaEnRevista . ou:tienePublicacion . ou:tienePublicacion .